4015 Stock Overview
Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 4015 from our risk checks.
Jamjoom Pharmaceuticals Factory Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س130.00 |
| 52 Week High | ر.س158.20 |
| 52 Week Low | ر.س66.00 |
| Beta | 0 |
| 1 Month Change | -3.27% |
| 3 Month Change | -8.71% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 66.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4015 | SA Pharmaceuticals | SA Market | |
|---|---|---|---|
| 7D | -1.4% | 3.7% | -0.4% |
| 1Y | n/a | 1.4% | -2.8% |
Return vs Industry: Insufficient data to determine how 4015 performed against the SA Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 4015 performed against the SA Market.
Price Volatility
| 4015 volatility | |
|---|---|
| 4015 Average Weekly Movement | 4.4% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SA Market | 8.2% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 4015 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4015's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,255 | Tarek Youssef Hosni | www.jamjoompharma.com |
Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.
Jamjoom Pharmaceuticals Factory Company Fundamentals Summary
| 4015 fundamental statistics | |
|---|---|
| Market cap | ر.س9.10b |
| Earnings (TTM) | ر.س292.40m |
| Revenue (TTM) | ر.س1.10b |
31.1x
P/E Ratio8.3x
P/S RatioIs 4015 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4015 income statement (TTM) | |
|---|---|
| Revenue | ر.س1.10b |
| Cost of Revenue | ر.س399.08m |
| Gross Profit | ر.س701.74m |
| Other Expenses | ر.س409.34m |
| Earnings | ر.س292.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.18 |
| Gross Margin | 63.75% |
| Net Profit Margin | 26.56% |
| Debt/Equity Ratio | 0% |
How did 4015 perform over the long term?
See historical performance and comparison